Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.89 |
| ▸ | CA4 | P22748 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL152373 | 1.00 | — | — | |
| Acetic Acid SCHEMBL28872874 | 0.95 | — | — | |
| Acetic Acid SCHEMBL28796500 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL28778844 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL2465078 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL28868516 | 0.95 | — | — | |
| Acetic Acid SCHEMBL9768644 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL10344391 | 0.95 | — | — | |
| Acetic Acid SCHEMBL2466189 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL29105322 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122048389-A | Edible vinegar production area traceability model construction method based on carbon acetate isotope and mineral elements | 中国地质大学（北京） | 2026-05-15 | — | — | CN | claimed |
| CN-117342687-A | Ecological management method for aquaculture tail water based on Internet of things | 广东绿日环境科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-109082454-B | Method for measuring low-concentration assimilable organic carbon | 中国人民解放军陆军工程大学 | 2021-11-09 | — | — | CN | claimed |
| CN-113470989-A | One-step carbonization activation method for preparing high-performance self-supporting carbon nanofiber membrane for super capacitor electrode material | 南京林业大学 | 2021-10-01 | — | — | CN | claimed |
| CN-113373596-A | Preparation method of metal salt modified cellulose acetate carbon nanofiber membrane for supercapacitor electrode material | 南京林业大学 | 2021-09-10 | — | — | CN | claimed |
| CN-113135836-A | Preparation method of Sacubitril calcium salt | 鲁南制药集团股份有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-113135841-A | Preparation method of Sacubitril intermediate | 鲁南制药集团股份有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-107607655-B | Method and system for measuring carbon acetate stable isotope in Maotai-flavor liquor | 贵州省产品质量监督检验院 | 2021-04-27 | — | — | CN | claimed |
| US-10314812-B2 | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same | HUMANETICS CORPORATION (US) | 2019-06-11 | — | — | US | claimed |
| US-20190038593-A1 | SUSPENSION COMPOSITIONS OF PHYSIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS & METHODS OF MAKING AND USING THE SAME | HUMANETICS CORPORATION (US) | 2019-02-07 | — | — | US | claimed |
| US-20060039861-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC., A DELAWARE CORPORATION | 2006-02-23 | — | — | US | claimed |
| CN-2732877-Y | Aeroconcrete self-thermal-insulation wall | CHANGZHOU NIGAO SCIENCE & TECH (CN) | 2005-10-12 | — | — | CN | claimed |
| CN-1599577-A | Peptide-based multimeric targeted contrast media | EPIX MEDICAL INC (US) | 2005-03-23 | — | — | CN | claimed |
| CN-1176205-C | Acetic acid leakage type high-yield pyruvate bacterium and its breeding method and producing pyruvic acid by said bacterium via fermentation process | 江南大学 | 2004-11-17 | — | — | CN | claimed |
| EP-1420681-A2 | PEPTIDE-BASED MULTIMERIC TARGETED CONTRAST AGENTS | Epix Medical, Inc. (US) | 2004-05-26 | — | — | EP | claimed |
| US-20030180222-A1 | Peptide-based multimeric targeted contrast agents | EPIX PHARMACEUTICALS, INC. | 2003-09-25 | — | — | US | claimed |
| WO-2003011115-A2 | PEPTIDE-BASED MULTIMERIC TARGETED CONTRAST AGENTS | EPIX MEDICAL, INC. (US) | 2003-02-13 | — | — | WO | claimed |
| CN-1392246-A | Acetic acid leakage type high-yield pyruvate bacterium and its breeding method and producing pyruvic acid by said bacterium via fermentation process | UNIV JIANGNAN (CN) | 2003-01-22 | — | — | CN | claimed |
| EP-0689776-B1 | Cigarette paper tube with two-part filter | EFKA WERKE KIEHN GMBH FRITZ (DE) | 2002-01-02 | — | — | EP | claimed |
| US-6242229-B1 | TOPICALLY APPLYING COMPOSITION INCLUDING CLARIFIED AND STABILIZED CULTURE MEDIUM FROM NON-PHOTOSYNTHETIC FILAMENTOUS BACTERIUM TO SKIN, SCALP, OR MUCOUS MEMBRANES; REDUCES OR DELAYS AGING OF SKIN | SOCIETE L'OREAL S.A. (FR) | 2001-06-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180222-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | CA1 1223/4885CA4 1056/4885LMNA 3453/4885 |
| US-20060039861-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | CA1 1223/4885CA4 1056/4885LMNA 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.